Edison Liu, MD, is the President and CEO of The Jackson Laboratory (JAX), an independent, not-for-profit organization focusing on mammalian genetics and functional genomics research to advance human health. At the Laboratory, he has overseen initiatives including the opening of a new genomics research campus in Connecticut, the development and growth of strong research programs in new areas including immunology and the microbiome, the renewal of NCI designation for JAX’s Cancer Center, the launch of a collaborative Maine Cancer Genomics Initiative to expand access to genomic medicine, and the expansion of philanthropic support for the Laboratory, including the two largest gifts in JAX’s history.
Dr. Liu, who was the Past President of the Human Genome Organisation, was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2016. He served from 2001 to 2012 as the Founding Executive Director of the Genome Institute of Singapore, a major research institute of 27 laboratory groups and a staff of 270, with faculty in functional genomics, computational biology, population genetics and genome-to-systems biology. Before moving to Singapore in 2001, Dr. Liu was the Scientific Director of the National Cancer Institute’s then Division of Clinical Sciences in Bethesda, Maryland.
Dr. Liu’s research has focused on the functional genomics of human cancers, particularly breast cancer, uncovering new oncogenes and deciphering the dynamics of gene regulation on a genomic scale. His current work focuses on the genomic dynamics of triple negative breast cancer that has an impact on drug sensitivity and resistance. He has authored over 300 scientific papers and reviews and co-authored two books.
Dr. Liu obtained his BSc. in Chemistry and Psychology and his MD degree at Stanford University.